News
In this expert perspective, Manjot K. Gill, MD, discusses the potential FDA approval in 2025 of aflibercept 8 mg for the treatment of retinal vein occlusion.
Multiple pharmaceutical agents in clinical trials promise to offer patients eye drops for the management of presbyopia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback